The right test at the right time
The following pages are a reference to the age-based well-woman screening recommendations from both ACOG and the CDC, with the corresponding Quest tests. Together, it helps to ensure your patients get the testing they need at every well-woman visit at every age.
View periodic screening for: Ages 13-39 | Ages 40-64 | Ages 65-older
PERIODIC SCREENING
Ages 13-18 1, d
| ACOG RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Annual chlamydia and gonorrhea testing (if sexually active) | Chlamydia trachomatis/Neisseria gonorrhoeae RNA, TMA (Aptima® collection) | 11363 |
| Human immunodeficiency virus (HIV) testing (if sexually active)a | HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesb | 91431 |
| ADDITIONAL CDC RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Screening for chlamydia and gonorrhea (if sexually active) | Chlamydia trachomatis/Neisseria gonorrhoeae RNA, TMA (Aptima collection) | 11363 |
| Screening for trichomonas when risk factors are identifiede | SureSwab® Trichomonas vaginalis RNA, Qualitative TMA | 19550 |
Ages 19-39 2
| ACOG RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Annual chlamydia and gonorrhea testing (under 25 and if sexually active and for older women who are at increased risk for infectiond) | Chlamydia trachomatis/Neisseria gonorrhoeae RNA, TMA (Aptima collection) | 11363 |
Cervical Cancer Screening Recommended to start at age 21
Or | Image-Guided Pap w. Age-Based Screening Protocols Image-Guided Pap w. Age-Based Screening, Plus CT/NG Image-Guided Pap w. Age-Based Screening, Plus CT/NG/Trich Pap alone | 91384c 91385c 91386c See note belowc |
| Human immunodeficiency virus (HIV) testinga | HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesb | 91431 |
| ADDITIONAL CDC RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Screening for chlamydia and gonorrhea (under age 25 and if sexually active; for ages 25 and over when risk factors are identifiede) | Chlamydia trachomatis/Neisseria gonorrhoeae RNA, TMA (Aptima collection) | 11363 |
| Screening for trichomonas when risk factors are identifiede | SureSwab Trichomonas vaginalis RNA, Qualitative TMA | 19550 |
a. Healthcare providers should always follow state HIV screening requirements. For more information, visit www.cdc.gov and search for the September 22, 2006 issue of MMWR™ Recommendations and Reports.
b. Reflex testing may be performed at an additional charge.
c. The age-based (Smart Codes) offerings are based on ACOG recommendations and include image-guided Pap tests. The ACOG guidelines do not specify a particular type of Pap test. Both imaged and non-imaged Pap tests are acceptable under the guidelines. Non-imaged Paps, conventional Paps, as well as additional testing recommended by the guidelines, may be ordered individually and are available at Quest Diagnostics. Test codes may vary by location. Please contact your local laboratory or go to QuestDiagnostics.com/TestDirectory for more information.
d. Positive results may need to be reported to the authorities under applicable law.
Additional assessments and recommendations may be necessary for patients with certain risk factors. For more information, visit acog.org and search for Well-Woman Recommendations.
e. The top risk factors are inconsistent use of condoms, multiple sex partners, and previous STI infection.
PERIODIC SCREENING
Ages 40-64 3
| ACOG RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Annual mammography | N/A | N/A |
| Diabetes testing every 3 years after age 45 | Glucose Hemoglobin A1c Cardio IQ® Diabetes Risk Panel (with Score)a* Diabetes Risk Panel (with Score)* Cardio IQ® Insulin Resistance Panel (with Score)* | 67777W 496X 92026 92027 36509 |
Cervical Cancer Screening
Or | Image-Guided Pap w. Age-Based Screening Protocols Image-Guided Pap w. Age-Based Screening, Plus CT/NG Image-Guided Pap w. Age-Based Screening, Plus CT/NG/Trich Pap alone | 91384b 91385b 91386b See note belowb |
| Lipid profile assessment every 5 years beginning at age 45 | Lipid Panel* Cardio IQ ASCVD Risk Panel (with Score)a* ASCVD Risk Panel (with Score)* Cardio IQ Advanced Lipid Panel with Inflammation* | 968T 92052 92053 94220 |
| Thyroid-stimulating hormone testing every 5 years beginning at age 50 | TSH (without Reflex) TSH with Reflex to Free T4 Thyroid Panel with TSH* | 30163E 36127 7444 |
| Colorectal cancer screening with colonoscopy every 10 years beginning at age 50 or at age 45 for African-American women (preferred); fecal immunochemical test (FIT) annually starting at age 50 as an alternative to colonoscopy | InSure® ONE™ | 11290 |
| Human immunodeficiency virus (HIV) testingc | HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesd | 91431 |
| One-time hepatitis C testing for persons born from 1945 through 1965 and unaware of their infection status | Hepatitis C Antibody with Reflex to HCV RNA | 8472 |
a. To learn more about our Cardio IQ testing, visit QuestDiagnostics.com/CardioIQ.
b. The age-based offerings are based on ACOG recommendations and include image-guided Pap tests. The ACOG guidelines do not specify a particular type of Pap test. Both imaged and non-imaged Pap tests are acceptable under the guidelines. Non-imaged Paps, conventional Paps, as well as additional testing recommended by the guidelines, may be ordered individually and are available at Quest Diagnostics. Test codes may vary by location. Please contact your local laboratory or go to QuestDiagnostics.com/TestDirectory for more information.
c. Healthcare providers should always follow state HIV screening requirements. For more information, visit cdc.gov, and search for the September 22, 2006 issue of MMWR™ Recommendations and Reports.
d. Reflex testing may be performed at an additional charge.
Additional assessments and recommendations may be necessary for patients with certain risk factors. For more information, visit acog.org, and search for Well-Woman Recommendations.
Rely on BRCAvantage from Quest Diagnostics
ACOG recommends that OB/GYNs perform a hereditary cancer risk assessment to help identify patients who may be at risk of developing certain types of cancer.4 When you have a patient with a family or personal history of breast or ovarian cancer or Ashkenazi Jewish ancestry, BRCA testing can give you the valuable information you need to make the best treatment decisions. Our BRCAvantage™ testing is performed on a next-generation sequencing platform in conjunction with our proprietary software to allow for the most accurate identification of disease. Ask your Quest Diagnostics sales representative for more information, or visit BRCAvantage.com.
Ages 40-64 4
| ADDITIONAL CDC RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Screening for chlamydia, gonorrhea, and trichomonas when risk factors are identifieda | Chlamydia trachomatis/Neisseria gonorrhoeae RNA, TMA (Aptima collection) SureSwab Trichomonas vaginalis RNA, Qualitative TMA | 11363 19550 |
a. The top risk factors are inconsistent use of condoms, multiple sex partners, and previous STI infection.
PERIODIC SCREENING
Ages 65-older 5
| ACOG RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Annual mammography | N/A | N/A |
| Annual urinalysis | Urinalysis, Macroscopic Urinalysis with Reflex Microscopic | 232A 86702A |
| Bone mineral density screening with bone densitometry every 2 years, unless new risk factors are present | N/Aa | N/Aa |
| Diabetes testing every 3 years | Glucose Hemoglobin A1c Cardio IQ® Diabetes Risk Panel (with Score)b* Diabetes Risk Panel (with Score)* Cardio IQ Insulin Resistance Panel (with Score)* | 67777W 496X 92026 92027 36509 |
| Lipid profile assessment every 5 years | Lipid Panel* Cardio IQ ASCVD Risk Panel (with Score)b* ASCVD Risk Panel (with Score)* Cardio IQ Advanced Lipid Panel with Inflammation* | 968T 92052 92053 94220 |
| Thyroid-stimulating hormone testing every 5 years | TSH (without Reflex) TSH with Reflex to Free T4 Thyroid Panel with TSH* | 30163E 36127 7444 |
| Colorectal cancer screening with colonoscopy every 10 years, beginning at age 45. Fecal immunochemical test (FIT) annually, starting at age 50 as an alternative to colonoscopy | InSure® ONE™ | 11290 |
Cervical Cancer Screening
| Image-Guided Pap with Age-Based Screening Protocols (only if indicated by patient history) | 91384c |
| One-time hepatitis C testing for persons born from 1945 through 1965 and unaware of their infection status | Hepatitis C Antibody with Reflex to HCV RNA | 8472 |
a. Lab testing may be useful in the therapeutic management of osteoporosis: Collagen Cross-Linked N-Telopeptide (NTx), urine: 36167(X) and Collagen Type 1 C-Telopeptide (CTx): 17406(X).
b. To learn more about our Cardio IQ testing, visit QuestDiagnostics.com/CardioIQ.
c. The age-based offerings are based on ACOG recommendations and include image-guided Pap tests. The ACOG guidelines do not specify a particular type of Pap test. Both imaged and non-imaged Pap tests are acceptable under the guidelines. Non-imaged Paps, conventional Paps, as well as additional testing recommended by the guidelines, may be ordered individually and are available at Quest Diagnostics. Test codes may vary by location. Please contact your local laboratory, or go to QuestDiagnostics.com/TestDirectory for more information.
Additional assessments and recommendations may be necessary for patients with certain risk factors. For more information, visit acog.org, and search for Well-Woman Recommendations.
Ages 65-older 5
| ADDITIONAL CDC RECOMMENDATIONS | CORRESPONDING QUEST TEST(S) | TEST CODE |
|---|---|---|
| Screening for chlamydia, gonorrhea, and trichomonas when risk factors are identifieda | Chlamydia trachomatis/Neisseria gonorrhoeae RNA, TMA (Aptima collection) SureSwab® Trichomonas vaginalis RNA, Qualitative TMA | 11363 19550 |
a. The top risk factors are inconsistent use of condoms, multiple sex partners, and previous STI infection.
*PANEL COMPONENTS
| Diabetes Risk Panel (with Score) Includes: Glucose Hemoglobin A1c Total Cholesterol HDL cholesterol Triglycerides Non-HDL and Calculated Components 8 Year Diabetes Risk Cardio IQ® Diabetes Risk Panel (with Score) Includes: Cardio IQ® Glucose Cardio IQ® Hemoglobin A1c Cardio IQ® Total Cholesterol Cardio IQ® HDL cholesterol Cardio IQ® Triglycerides Cardio IQ® Non-HDL and Calculated Components Cardio IQ® 8 Year Diabetes Risk Cardio IQ® Insulin resistance Panel (with Score) Includes: Insulin, Intact LC/MS/MS C-Peptide, LC/MS/MS Insulin Resistance Score Lipid Panel Includes: Cholesterol, Total Triglycerides HDL Cholesterol LDL-Cholesterol (calculated) Cholesterol/HDL Ratio (calculated) Non-HDL Cholesterol (calculated) | Cardio IQ® Risk Panel (with Score) Includes: Cardio IQ® Cholesterol, Total Cardio IQ® HDL Cholesterol Cardio IQ® Triglycerides Cardio IQ® Non-HDL and Calculated Components Cardio IQ® Direct LDL Cardio IQ® ASCVD Risk Scores ASCVD Risk Panel (with Score) Includes: Cholesterol, Total HDL Cholesterol Triglycerides Non-HDL and Calculated Components Cholesterol, Direct LDL ASCVD Risk Scores Cardio IQ® Advanced Lipid Panel with Inflammation Includes: Cardio IQ® Cholesterol, Total Cardio IQ® HDL Cholesterol Cardio IQ® Triglycerides Cardio IQ® Non-HDL and Calculated Components Cardio IQ® Lipoprotein Fractionation, Ion Mobility Cardio IQ® Apolipoprotein B Cardio IQ® Lipoprotein (a) Cardio IQ® hs-CRP Cardio IQ® Lp-PLA2 Activity Thyroid Panel Includes: T3 Uptake T4 (thyroxine) Total Free T4 Index (T7) TSH |
References:
1. The American College of Obstetricians and Gynecologists. Ages 13–18 years: laboratory and other tests. https://acog.org/About-ACOG/ACOG-Departments/Annual-Womens-Health-Care/Well-Woman-Recommendations/Laboratory-Testing-Ages-13-18-Years. Accessed September 23, 2019.
2. The American College of Obstetricians and Gynecologists. Ages 19–39 years: laboratory and other tests. https://acog.org/About-ACOG/ACOG-Departments/Annual-Womens-Health-Care/Well-Woman-Recommendations/laboratory-testing-Ages-19-39-Years. Accessed September 23, 2019.
3. The American College of Obstetricians and Gynecologists. Ages 40–64 years: laboratory and other tests. https://acog.org/About-ACOG/ACOG-Departments/Annual-Womens-Health-Care/Well-Woman-Recommendations/Laboratory-Testing-Ages-40-64-Years. Accessed September 23, 2019.
4. The American College of Obstetricians and Gynecologists. Committee opinion no. 634: hereditary cancer syndromes and risk assessment. Obstet Gynecol. 2015;125(6):1538-1543.
5. The American College of Obstetricians and Gynecologists. Ages 65 years and older: laboratory and other tests. http://acog.org/About-ACOG/ACOG-Departments/Annual-Womens-Health-Care/Well-Woman-Recommendations/laboratory-testing-Ages-65-years-and-older. September 23, 2019.